View Item 

Show simple item record

Reducing the Global Burden of Alcohol‐Associated Liver Disease: A Blueprint for Action
dc.contributor.authorAsrani, Sumeet K.
dc.contributor.authorMellinger, Jessica
dc.contributor.authorArab, Juan P.
dc.contributor.authorShah, Vijay H.
dc.date.accessioned2021-05-12T17:23:05Z
dc.date.available2022-06-12 13:23:03en
dc.date.available2021-05-12T17:23:05Z
dc.date.issued2021-05
dc.identifier.citationAsrani, Sumeet K.; Mellinger, Jessica; Arab, Juan P.; Shah, Vijay H. (2021). "Reducing the Global Burden of Alcohol‐Associated Liver Disease: A Blueprint for Action." Hepatology (5): 2039-2050.
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.urihttps://hdl.handle.net/2027.42/167452
dc.publisherWiley Periodicals, Inc.
dc.publisherWHO
dc.titleReducing the Global Burden of Alcohol‐Associated Liver Disease: A Blueprint for Action
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/167452/1/hep31583-sup-0001-Supinfo.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/167452/2/hep31583_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/167452/3/hep31583.pdf
dc.identifier.doi10.1002/hep.31583
dc.identifier.sourceHepatology
dc.identifier.citedreferenceGines P, Graupera I, Lammert F, Angeli P, Caballeria L, Krag A, et al. Screening for liver fibrosis in the general population: a call for action. Lancet Gastroenterol Hepatol 2016; 1: 256 ‐ 260.
dc.identifier.citedreferenceJernigan D, Noel J, Landon J, Thornton N, Lobstein T. Alcohol marketing and youth alcohol consumption: a systematic review of longitudinal studies published since 2008. Addiction 2017; 112 ( Suppl. 1 ): 7 ‐ 20.
dc.identifier.citedreferenceMaani Hessari N, Bertscher A, Critchlow N, Fitzgerald N, Knai C, Stead M, et al. Recruiting the “Heavy‐Using Loyalists of Tomorrow”: an analysis of the aims, effects and mechanisms of alcohol advertising, based on advertising industry evaluations. Int J Environ Res Public Health 2019; 16: 4092.
dc.identifier.citedreferenceKanwal F, Mapaskhi S, Smith D, Taddei T, Hussain K, Madu S, et al. Implementation of a population‐based cirrhosis identification and management system. Clin Gastroenterol Hepatol 2018; 16: 1182 ‐ 1186.e1182.
dc.identifier.citedreferenceWinder GS, Fernandez AC, Klevering K, Mellinger JL. Confronting the crisis of comorbid alcohol use disorder and alcohol‐related liver disease with a novel multidisciplinary clinic. Psychosomatics 2020; 61: 238 ‐ 253.
dc.identifier.citedreferenceWilliams R, Alexander G, Armstrong I, Baker A, Bhala N, Camps‐Walsh G, et al. Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK. Lancet 2018; 391: 1097 ‐ 1107.
dc.identifier.citedreferenceTalukdar R, Reddy DN. Making endoscopy mobile: a novel initiative for public healthcare. Endoscopy 2012; 44: 186 ‐ 189.
dc.identifier.citedreferencevan Ginneken N, Tharyan P, Lewin S, Rao GN, Meera SM, Pian J, et al. Non‐specialist health worker interventions for the care of mental, neurological and substance‐abuse disorders in low‐ and middle‐income countries. Cochrane Database Syst Rev 2013: CD009149.
dc.identifier.citedreferenceKhan A, Tansel A, White DL, Kayani WT, Bano S, Lindsay J, et al. Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review. Clin Gastroenterol Hepatol 2016; 14: 191 ‐ 202.e191‐194; quiz e120.
dc.identifier.citedreferenceKaner EF, Beyer FR, Garnett C, Crane D, Brown J, Muirhead C, et al. Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community‐dwelling populations. Cochrane Database Syst Rev 2017; 9: CD011479.
dc.identifier.citedreferenceKomaromy M, Duhigg D, Metcalf A, Carlson C, Kalishman S, Hayes L, et al. Project ECHO (Extension for Community Healthcare Outcomes): a new model for educating primary care providers about treatment of substance use disorders. Subst Abus 2016; 37: 20 ‐ 24.
dc.identifier.citedreferenceCrabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol‐associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2020; 71: 306 ‐ 333.
dc.identifier.citedreferenceEuropean Association for the Study of the Liver. EASL clinical practice guidelines: management of alcohol‐related liver disease. J Hepatol 2018; 69: 154 ‐ 181.
dc.identifier.citedreferenceHedden SL, Kennet J, Lipari R, Medley G, Tice P. Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health. Publication No. SMA 15‐4927, NSDUH Series H‐50, 2015.
dc.identifier.citedreferenceMellinger JL, Fernandez A, Shedden K, Winder GS, Fontana RJ, Volk ML, et al. Gender disparities in alcohol use disorder treatment among privately insured patients with alcohol‐associated cirrhosis. Alcohol Clin Exp Res 2019; 43: 334 ‐ 341.
dc.identifier.citedreferenceMellinger JL, Scott Winder G, DeJonckheere M, Fontana RJ, Volk ML, Lok ASF, et al. Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol‐related cirrhosis. J Subst Abuse Treat 2018; 91: 20 ‐ 27.
dc.identifier.citedreferenceColle I, Durand F, Pessione F, Rassiat E, Bernuau J, Barriere E, et al. Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis. J Gastroenterol Hepatol 2002; 17: 882 ‐ 888.
dc.identifier.citedreferenceCrabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol‐related liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2020; 71: 306 ‐ 333.
dc.identifier.citedreferenceNdugga N, Lightbourne TG, Javaherian K, Cabezas J, Verma N, Barritt AS, et al. Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA. BMJ Open 2017; 7: e013620.
dc.identifier.citedreferenceGBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990‐2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2018; 392: 1015 ‐ 1035.
dc.identifier.citedreferenceWorld Health Organization. Global Report on Alcohol and Related Conditions. Geneva, Switzerland: WHO; 2018.
dc.identifier.citedreferenceAsphaug L, Thiele M, Krag A, Melberg HO, The GALAXY Consortium. Cost‐effectiveness of noninvasive screening for alcohol‐related liver fibrosis. Hepatology 2020; 71: 2093 ‐ 2104.
dc.identifier.citedreferenceSerper M, Cubell AW, Deleener ME, Casher TK, Rosenberg DJ, Whitebloom D, et al. Telemedicine in liver disease and beyond: can the COVID‐19 crisis lead to action? Hepatology 2020; 72: 723 ‐ 728.
dc.identifier.citedreferenceArora S, Thornton K, Murata G, Deming P, Kalishman S, Dion D, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011; 364: 2199 ‐ 2207.
dc.identifier.citedreferenceDas J, Chowdhury A, Hussam R, Banerjee AV. The impact of training informal health care providers in India: a randomized controlled trial. Science 2016; 354: aaf7384.
dc.identifier.citedreferenceGBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990‐2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020; 5: 245 ‐ 266.
dc.identifier.citedreferenceAmerican Psychiatric Association, American Psychiatric Association, DSM‐5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM‐5. 5 th ed. Arlington, VA: American Psychiatric Association; 2013: xliv, 947.
dc.identifier.citedreferenceGlantz MD, Bharat C, Degenhardt L, Sampson NA, Scott KM, Lim CCW, et al. The epidemiology of alcohol use disorders cross‐nationally: findings from the World Mental Health Surveys. Addict Behav 2020; 102: 106128.
dc.identifier.citedreferenceGrant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, et al. Epidemiology of DSM‐5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatr 2015; 72: 757 ‐ 766.
dc.identifier.citedreferenceSarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, et al. Liver diseases in the Asia‐Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol 2020; 5: 167 ‐ 228.
dc.identifier.citedreferenceMenon GR, Singh L, Sharma P, Yadav P, Sharma S, Kalaskar S, et al. National burden estimates of healthy life lost in India, 2017: an analysis using direct mortality data and indirect disability data. Lancet Glob Health 2019; 7: e1675 ‐ e1684.
dc.identifier.citedreferencePimpin L, Cortez‐Pinto H, Negro F, Corbould E, Lazarus JV, Webber L, et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol 2018; 69: 718 ‐ 735.
dc.identifier.citedreferenceGlobal Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol 1990; 2017: 1683 ‐ 1691.
dc.identifier.citedreferenceWong T, Dang K, Ladhani S, Singal AK, Wong RJ. Prevalence of alcoholic fatty liver disease among adults in the United States, 2001‐2016. JAMA 2019; 321: 1723 ‐ 1725.
dc.identifier.citedreferenceAsrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR. Underestimation of liver‐related mortality in the United States. Gastroenterology 2013; 145: 375 ‐ 382.e371‐372.
dc.identifier.citedreferenceGuirguis J, Chhatwal J, Dasarathy J, Rivas J, McMichael D, Nagy LE, et al. Clinical impact of alcohol‐related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States. Alcohol Clin Exp Res 2015; 39: 2085 ‐ 2094.
dc.identifier.citedreferenceMellinger JL, Shedden K, Winder GS, Tapper E, Adams M, Fontana RJ, et al. The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology 2018; 68: 872 ‐ 882.
dc.identifier.citedreferenceSerra‐Burriel M, Graupera I, Toran P, Thiele M, Roulot D, Wai‐Sun Wong V, et al. Transient elastography for screening of liver fibrosis: cost‐effectiveness analysis from six prospective cohorts in Europe and Asia. J Hepatol 2019; 71: 1141 ‐ 1151.
dc.identifier.citedreferenceColbert S, Thornton L, Richmond R. Smartphone apps for managing alcohol consumption: a literature review. Addict Sci Clin Pract 2020; 15: 17.
dc.identifier.citedreferenceWestwood G, Meredith P, Atkins S, Greengross P, Schmidt PE, Aspinall RJ. Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease. J Hepatol 2017; 67: 559 ‐ 567.
dc.identifier.citedreferenceVictor RG, Lynch K, Li N, Blyler C, Muhammad E, Handler J, et al. A cluster‐randomized trial of blood‐pressure reduction in black barbershops. N Engl J Med 2018; 378: 1291 ‐ 1301.
dc.identifier.citedreferenceLouissaint J, Lok AS, Fortune BE, Tapper EB. Acceptance and use of a smartphone application in cirrhosis. Liver Int 2020; 40: 1556 ‐ 1563.
dc.identifier.citedreferenceSheron N, Moore M, O’Brien W, Harris S, Roderick P. Feasibility of detection and intervention for alcohol‐related liver disease in the community: the Alcohol and Liver Disease Detection Study (ALDDeS). Br J Gen Pract 2013; 63: e698 ‐ e705.
dc.identifier.citedreferenceJohnson JA, Lee A, Vinson D, Seale JP. Use of AUDIT‐based measures to identify unhealthy alcohol use and alcohol dependence in primary care: a validation study. Alcohol Clin Exp Res 2013; 37 ( Suppl. 1 ): E253 ‐ E259.
dc.identifier.citedreferenceBush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT‐C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998; 158: 1789 ‐ 1795.
dc.identifier.citedreferencePal HR, Jena R, Yadav D. Validation of the Alcohol Use Disorders Identification Test (AUDIT) in urban community outreach and de‐addiction center samples in north India. J Stud Alcohol 2004; 65: 794 ‐ 800.
dc.identifier.citedreferenceFleming MF, Smith MJ, Oslakovic E, Lucey MR, Vue JX, Al‐Saden P, et al. Phosphatidylethanol detects moderate‐to‐heavy alcohol use in liver transplant recipients. Alcohol Clin Exp Res 2017; 41: 857 ‐ 862.
dc.identifier.citedreferenceLee BP, Terrault NA. Return to alcohol use after liver transplant: patterns and surveillance. Clin Liver Dis (Hoboken) 2018; 12: 160 ‐ 164.
dc.identifier.citedreferenceParkes J, Roderick P, Harris S, Day C, Mutimer D, Collier J, et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut 2010; 59: 1245 ‐ 1251.
dc.identifier.citedreferenceThiele M, Madsen BS, Hansen JF, Detlefsen S, Antonsen S, Krag A. Accuracy of the enhanced liver fibrosis test vs fibrotest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease. Gastroenterology 2018; 154: 1369 ‐ 1379.
dc.identifier.citedreferenceAskgaard G, Kjaer MS, Tolstrup JS. Opportunities to prevent alcoholic liver cirrhosis in high‐risk populations: a systematic review with meta‐analysis. Am J Gastroenterol 2019; 114: 221 ‐ 232.
dc.identifier.citedreferenceRekve VPaD. Global Status Report on Alcohol and Health 2018: Executive Summary. Geneva, Switzerland: World Health Organization; 2018.
dc.identifier.citedreferenceO’Donnell A, Anderson P, Jane‐Llopis E, Manthey J, Kaner E, Rehm J. Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015‐18. BMJ 2019; 366: l5274.
dc.identifier.citedreferenceJiang H, Livingston M, Room R, Callinan S, Marzan M, Brennan A, et al. Modelling the effects of alcohol pricing policies on alcohol consumption in subpopulations in Australia. Addiction 2020; 115: 1038 ‐ 1049.
dc.identifier.citedreferenceWagenaar AC, Tobler AL, Komro KA. Effects of alcohol tax and price policies on morbidity and mortality: a systematic review. Am J Public Health 2010; 100: 2270 ‐ 2278.
dc.identifier.citedreferenceNeufeld M, Rehm J. Effectiveness of policy changes to reduce harm from unrecorded alcohol in Russia between 2005 and now. Int J Drug Policy 2018; 51: 1 ‐ 9.
dc.identifier.citedreferenceArab JP, Roblero JP, Altamirano J, Bessone F, Chaves Araujo R, Higuera‐De la Tijera F, et al. Alcohol‐related liver disease: clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann Hepatol 2019; 18: 518 ‐ 535.
dc.identifier.citedreferenceGray‐Phillip G, Huckle T, Callinan S, Parry CDH, Chaiyasong S, Cuong PV, et al. Availability of alcohol: location, time and ease of purchase in high‐ and middle‐income countries: data from the International Alcohol Control Study. Drug Alcohol Rev 2018; 37 ( Suppl. 2 ): S36 ‐ S44.
dc.identifier.citedreferenceCasswell S, Huckle T, Wall M, Parker K, Chaiyasong S, Parry CDH, et al. Policy‐relevant behaviours predict heavier drinking and mediate the relationship with age, gender and education status: analysis from the International Alcohol Control Study. Drug Alcohol Rev 2018; 37 ( Suppl. 2 ): S86 ‐ S95.
dc.identifier.citedreferenceWhite V, Azar D, Faulkner A, Coomber K, Durkin S, Livingston M, et al. Adolescents’ alcohol use and strength of policy relating to youth access, trading hours and driving under the influence: findings from Australia. Addiction 2018; 113: 1030 ‐ 1042.
dc.identifier.citedreferenceWagenaar AC, Toomey TL. Effects of minimum drinking age laws: review and analyses of the literature from 1960 to 2000. J Stud Alcohol Suppl 2002; s14: 206 ‐ 225.
dc.identifier.citedreferencePlunk AD, Krauss MJ, Syed‐Mohammed H, Hur M, Cavzos‐Rehg PA, Bierut LJ, et al. The impact of the minimum legal drinking age on alcohol‐related chronic disease mortality. Alcohol Clin Exp Res 2016; 40: 1761 ‐ 1768.
dc.identifier.citedreferenceYoung E. How Iceland got teens to say no to drugs. The Atlantic; 2017 Jan 19.
dc.identifier.citedreferenceFinan LJ, Lipperman‐Kreda S, Grube JW, Balassone A, Kaner E. Alcohol marketing and adolescent and young adult alcohol use behaviors: a systematic review of cross‐sectional studies. J Stud Alcohol Drugs Suppl 2020; 19: 42 ‐ 56.
dc.identifier.citedreferenceIbitoye M, Kaaya S, Parker R, Likindikoki S, Ngongi L, Sommer M. The influence of alcohol outlet density and advertising on youth drinking in urban Tanzania. Health Place 2019; 58: 102141.
dc.identifier.citedreferencePettigrew S, Jongenelis MI, Glance D, Chikritzhs T, Pratt IS, Slevin T, et al. The effect of cancer warning statements on alcohol consumption intentions. Health Educ Res 2016; 31: 60 ‐ 69.
dc.identifier.citedreferencede Bruijn A, Tanghe J, de Leeuw R, Engels R, Anderson P, Beccaria F, et al. European longitudinal study on the relationship between adolescents’ alcohol marketing exposure and alcohol use. Addiction 2016; 111: 1774 ‐ 1783.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep31583-sup-0001-Supinfo.pdf
Size:
63.49KB
Format:
PDF
View/Open
Name:
hep31583_am.pdf
Size:
411.4KB
Format:
PDF
View/Open
Name:
hep31583.pdf
Size:
236.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.